Obsessive-Compulsive Disorder (OCD) Clinical Trials

Find Obsessive-Compulsive Disorder (OCD) Clinical Trials Near You

Subcortical OCD Neuromodulation With Acoustic Therapy - Dose Duration Optimization

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Phase 2
SUMMARY

This study is testing a new, non-invasive brain stimulation approach for adults with Obsessive Compulsive Disorder (OCD). Researchers are evaluating the safety, tolerability, and target engagement of low-intensity focused ultrasound (LIFU) directed at a brain region called the subthalamic nucleus (STN). The ultrasound is delivered using a wearable device called ATTN201 (developed by Attune Neurosciences).

Eligibility
Participation Requirements
Sex: All
Minimum Age: 22
Maximum Age: 80
Healthy Volunteers: f
View:

• Age 22-80

• Meet DSM-V criteria for OCD ≥ 1 year with a Y-BOCS score ≥ 16

• Must be on the same stable dose(s) of OCD medication for at least 4 weeks prior to screening and throughout the course of the study

Locations
United States
Pennsylvania
University of Pennsylvania
RECRUITING
Philadelphia
Contact Information
Primary
Rishi Suresh
rishi.suresh1@pennmedicine.upenn.edu
215-746-8901
Backup
Giovanna Rocchio
giovanna.rocchio@pennmedicine.upenn.edu
Time Frame
Start Date: 2026-09-15
Estimated Completion Date: 2028-09-15
Participants
Target number of participants: 20
Treatments
Experimental: Active Stimulation
Participants receive low intensity focused ultrasound stimulation
Sham_comparator: Sham Stimulation
Participants received unfocused ultrasound, which mimic the auditory and peripheral sensations of active stimulation without delivering meaningful pressure to the brain target
Related Therapeutic Areas
Sponsors
Leads: University of Pennsylvania

This content was sourced from clinicaltrials.gov